Resultados de búsqueda - Qingming Yang

  • Mostrando 1 - 1 Resultados de 1
Limitar resultados
  1. 1
    Balance and management of CRS and infection following CD19-targeted CAR T-cell therapy in primary refractory high-grade B-cell lymphoma: a case report

    Balance and management of CRS and infection following CD19-targeted CAR T-cell therapy in primary refractory high-grade B-cell lymphoma: a case report por Nannan Lu, Nannan Lu, Yajing Zhang, Chunmeng Wang, Qingming Yang, Guanghua Rong, Yang Liu, Weidong Han, Weidong Han

    Publicado 2025-07-01

    BackgroundCD19-targeted chimeric antigen receptor T (CAR T) cell therapy has revolutionized the treatment of refractory/relapsed B-cell malignancies. However, this therapy introduces significant safety concerns, including cytokine release syndrome (CRS) and infections, both of which can lead to life...

    Descripción completa

    Enlace del recurso
    Artículo

    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: